Piper Sandler analyst Paul Newsome lowered the firm’s price target on Allstate to $137 from $141 and keeps an Overweight rating on the shares. The Q2 reports are going to be a mixed quarter for many insurers, the analyst tells investors in a research note. The sector needs to get through what may be a number of earnings pre-announcements before the stocks can recover and reflect the “fairly good intermediate-term prospects for the companies,” says the firm.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ALL:
- ‘Load Up,’ Says Raymond James About These 2 ‘Strong Buy’ Stocks
- Allstate vs. MetLife: Which Insurance Stock is Better?
- IBM (NYSE:IBM) Preparing to Buy Apptio; Adding to Pile of Collaborations
- Philip Morris upgraded, Palantir downgraded: Wall Street’s top analyst calls
- Allstate initiated with an Equal Weight at Morgan Stanley